Edition:
India

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

637.55INR
24 Jul 2017
Change (% chg)

Rs5.00 (+0.79%)
Prev Close
Rs632.55
Open
Rs632.00
Day's High
Rs639.90
Day's Low
Rs629.60
Volume
379,714
Avg. Vol
904,402
52-wk High
Rs1,037.00
52-wk Low
Rs555.00

WCKH.NS

Chart for WCKH.NS

About

Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid... (more)

Overall

Beta: 0.91
Market Cap(Mil.): Rs69,936.77
Shares Outstanding(Mil.): 110.56
Dividend: 10.00
Yield (%): 1.58

Financials

  WCKH.NS Industry Sector
P/E (TTM): -- 13.56 17.15
EPS (TTM): -17.72 -- --
ROI: -3.62 -7.26 -5.60
ROE: -5.50 -6.80 -4.89

MEDIA-India's Wockhardt looks for greener pastures as U.S. FDA issues linger -Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

09 May 2017

MEDIA-Wockhardt to make antibiotics, drugs for U.S. market at third-party facilities, Dubai plant - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

18 Apr 2017

BRIEF-KPC Pharma to signs MOU with Swiss firm Wockhardt on sales of insulin related products in China

* Says it plans to signs MOU with Switzerland's Wockhardt on sales of insulin-related products in China

21 Mar 2017

MEDIA-India's Wockhardt Shendra plant yet to get Irish regulator's nod - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

10 Mar 2017

BUZZ-India's Wockhardt falls after FDA issues warning letter to unit

** Shares of Wockhardt fall as much as 6.5 pct to 701 rupees in early trade

02 Mar 2017

Earnings vs. Estimates